Subscribe
istock-691511636_sanjeri
sanjeri / iStockphoto.com
5 September 2018Americas

Italian research organisation extends collaboration with Merck & Co

Italy-based research organisation IRBM has signed a new agreement with Merck & Co in the peptides therapeutics area, extending the parties’ long-standing collaboration.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
AstraZeneca and Merck enter $8.5bn cancer therapy collaboration
31 July 2017   AstraZeneca has entered into an oncology collaboration with Merck, under which the companies will co-develop AstraZeneca’s Lynparza.
Americas
Merck continues to boost immunotherapy expertise with collaboration
20 November 2017   Merck has continued to strengthen its expertise in immunotherapy with the signing of a research collaboration and licence agreement with Cue Biopharma.


Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Americas
Litigation implications of the USPTO’s terminal disclaimer proposal
29 August 2024
Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Europe
Labour govt appoints new Minister with IP oversight
9 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024

More on this story

Americas
AstraZeneca and Merck enter $8.5bn cancer therapy collaboration
31 July 2017   AstraZeneca has entered into an oncology collaboration with Merck, under which the companies will co-develop AstraZeneca’s Lynparza.
Americas
Merck continues to boost immunotherapy expertise with collaboration
20 November 2017   Merck has continued to strengthen its expertise in immunotherapy with the signing of a research collaboration and licence agreement with Cue Biopharma.

More on this story

Americas
AstraZeneca and Merck enter $8.5bn cancer therapy collaboration
31 July 2017   AstraZeneca has entered into an oncology collaboration with Merck, under which the companies will co-develop AstraZeneca’s Lynparza.
Americas
Merck continues to boost immunotherapy expertise with collaboration
20 November 2017   Merck has continued to strengthen its expertise in immunotherapy with the signing of a research collaboration and licence agreement with Cue Biopharma.

More features

Gilead scores win in fake HIV drug dispute
Polsinelli grows roster with ex-corporate counsel
‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird
Sandoz wins $137.2m payout for lost profits in generic launch
Sanofi signs global rights deal to develop rare cancer therapy
Unified Patent Court visualised: Cases, divisions, and classes in charts
WBD to merge with firm to create ‘powerhouse’ practice
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers